جست‌وجوی استاد و پژوهشگر

• Neurodegenerative Diseases
• Gene Therapy
• Stem Cell Therapies
• +۵ مورد دیگر

Jeffrey Kordower is the founding Director of the ASU-Banner Neurodegenerative Disease Research Center and holds the Charlene and J. Orin Edson Distinguished Professorship at Arizona State University's Biodesign Institute. He is affiliated with the School of Life Sciences. Previously, he served at Rush University Medical Center for over 30 years. His research focuses on neural transplantation, gene/stem cell therapies, and the pathogenesis of neurodegenerative diseases like Parkinson's and Alzheimer's, with a particular emphasis on molecular mechanisms, aging effects, and neuroinflammation. Education: Ph.D. from The City University of New York. Research interests include disease-modifying therapies, protein aggregation (α-synuclein, tau), neuroprotective strategies, and translational models. He pioneered techniques in nonhuman primate studies and has advanced understanding of Parkinson's pathology through innovative models like the PIGMO mouse. His work bridges basic science and clinical applications, addressing challenges in biomarker development and therapeutic delivery. Publications highlight advancements in gene therapy (e.g., CaV1.3-shRNA for dyskinesia mitigation), cross-disease pathology comparisons, and novel therapeutic targets. Collaborations emphasize multidisciplinary approaches to neurodegenerative disorders.

• Plant Biotechnology
• Vaccine Development
• Molecular Biology
• +۳ مورد دیگر

Hugh Mason is an Associate Professor at the School of Life Sciences, Arizona State University . His research focuses on plant-based vaccine development, viral vector systems, and recombinant protein production. He has pioneered the use of plants for producing edible vaccines, including breakthrough studies on hepatitis B and norovirus antigens. Education: Postdoctoral training at Texas A&M University (1987–1992), Ph.D. in Cellular and Developmental Biology from the University of Arizona (1986), and B.S. in Molecular Biology from the University of Texas at Austin (1976). Research Interests: Development of plant-derived vaccines using geminiviral vectors, oral immunization strategies, and antibody production in plants. Key contributions include: Pioneering plant-based expression of hepatitis B surface antigen (1992) First human trials of edible vaccines (1998–2005) Development of rapid transient expression systems using bean yellow dwarf virus (2003) Grants & Funding: Major support from NIH-NIAID, DARPA, and industry partnerships. Active projects include Ebola immune complex vaccines and universal vaccine platforms. Labs & Teams: Lead researcher in ASU’s Biodesign Institute labs, collaborating with institutions such as the University of Arizona and Pfizer on vaccine development initiatives.

Pengyao Jiangمشاهده پروفایل

استادیار

• Genetics
• Evolution
• Genomics
• +۳ مورد دیگر

Pengyao Jiang is an Assistant Professor at Arizona State University's School of Life Sciences and the Biodesign Center for Mechanisms of Evolution. Her research focuses on the genetic basis of mutation processes in natural populations and their phenotypic consequences, using yeast and fruit flies as model systems. She holds a PhD in Ecology and Evolution from the University of Chicago (2010-2017) and a B.E. in Computer Science from East China Normal University (2006-2010). Research : Jiang’s lab investigates evolutionary mechanisms at the molecular level, integrating experimental genetics, bioinformatics, and quantitative modeling. Key areas include mutation rate variability, mutational robustness, and the genotype-to-phenotype map. Recent work includes studies on URA6 mutations in yeast and the impact of mutational robustness on evolvability. Teaching : Teaches courses on genetics, research techniques, and computational methods, including BIO 340 (General Genetics), BCH 392 (Intro to Research Techniques), and BIO 539 (Computing for Research). Awards/Grants : No specific awards listed, but active in securing research funding through grants (details not provided). Labs/Teams : Leads a lab focused on evolutionary genetics, with recent milestones including undergraduate thesis defenses and CRISPR plasmid cloning successes.

Marco Mangoneمشاهده پروفایل

دانشیار

• RNA Biology
• Alternative Polyadenylation
• miRNA Targeting
• +۷ مورد دیگر

Marco Mangone is an Associate Professor at Arizona State University (ASU), affiliated with the School of Life Sciences and the Biodesign Virginia G. Piper Center for Personalized Diagnostics . He joined ASU's faculty in August 2011 after completing a postdoctoral fellowship at New York University's Center for Genomics and Systems Biology. Education: Ph.D. in Molecular Biology from Cold Spring Harbor Laboratory (2006) Italian Laurea (Dottorato) in Computational Analysis of Single-Nucleotide Polymorphisms from La Sapienza University, Rome (2000) Research Interests: His work centers on understanding eukaryotic RNA transcription termination and the regulation of mRNA 3'Untranslated Regions (3'UTRs). He uses C. elegans as a model system to investigate mechanisms of alternative polyadenylation (APA) , miRNA targeting, and their roles in diseases like cancer, Alzheimer's, and Duchenne muscular dystrophy. His approach integrates high-throughput genomics , bioinformatics , genetics , and systems biology to explore fundamental questions about gene regulation at the post-transcriptional level. Grants & Service: NIH/NIGMS R01 GM118796-01 (2016–2021) PI: 100% funding, focusing on APA and miRNA regulation in C. elegans . Biology Graduate Program Director (2019–2023) and member of the Molecular & Cellular Biology Ph.D. Executive Committee (2011–2019). ASU Senate representative (2015–2020) and Residency Appeal Committee member (2015–present). Outreach & Labs: Dr. Mangone’s lab develops tools like the 3'LIFE assay and human 3'UTRome library. His outreach initiatives include K-12 lectures on genomics and public engagement through worm-based experiments. The lab collaborates with institutions like the Biodesign Institute and Texas A&M on translational research projects. Labs/Teams: Mangone Lab at ASU’s Biodesign Institute. Co-organizer of the Cold Spring Harbor Asia meeting on RNA Therapeutics (2025).

• Microbial Genetics
• Membrane Biology
• Drug Resistance
• +۳ مورد دیگر

Rajeev Misra is a Professor at Arizona State University's School of Life Sciences, affiliated with the Biodesign Center for Fundamental & Applied Microbiomics. His research focuses on bacterial outer membrane protein assembly and drug resistance mechanisms, particularly in Escherichia coli . Education: PhD in Microbiology from Adelaide University, Australia. Research Interests: Microbial genetics, membrane biology, antibiotic resistance, and β-barrel protein assembly. His work investigates protein targeting to bacterial outer membranes, drug efflux systems, and envelope stress responses. Grants & Funding: Multiple NIH grants supporting studies on outer membrane protein biogenesis and antibiotic resistance. Recent projects include NIH grants on envelope stress and efflux pump mechanisms. Labs/Teams: Leads research in the Biodesign Center, focusing on microbiology and molecular biology. Collaborates on projects involving drug resistance and bacterial pathogenesis.

• Biological Oceanography
• Marine Ecology
• Carbon Cycle
• +۳ مورد دیگر

Susanne Neuer is a Professor and Founding Director of the School of Ocean Futures at Arizona State University (ASU), part of the College for Global Futures/Global Futures Lab. She holds additional affiliations with the School of Life Sciences, Water Institute, and the Biodesign Center for Fundamental & Applied Microbiomics. Her research focuses on biological oceanography, marine ecology, and the role of ocean life in the carbon cycle, particularly in the subtropical Atlantic and Arctic regions. Neuer has led interdisciplinary studies on microplastics, harmful algal blooms, and the impacts of climate change on marine ecosystems. Education: Ph.D. in Biological Oceanography (Oregon State University), M.Sc. in Biological Oceanography (University of Washington), B.S. in Biology (University of Kiel). Research Interests: Her work bridges microbial processes, biogeochemical cycles, and ecosystem dynamics. Key areas include carbon sequestration via the biological pump, microplastic colonization by microbes, and Arctic sea ice algae dynamics. She has pioneered studies on zooplankton mediation of particle flux and the influence of environmental variables on microbial communities. Grants & Leadership: Neuer has secured over $2.3 million in grants from NSF, NASA, and industry partners. She chairs the Ocean Carbon & Biogeochemistry (OCB) steering committee and served as President of ASU’s Faculty Women’s Association. Her leadership extends to organizing international conferences and promoting diversity in STEM. Outreach & Education: She develops innovative curricula for ocean futures education and engages in public outreach through initiatives like 'SoLS Takes a Hike.' Her research lab, the Neuer Lab, emphasizes collaborative, interdisciplinary training for students and early-career scientists.

• Molecular Endocrinology
• Gene-Environment Interactions
• Anti-Aging Gene Expression
• +۷ مورد دیگر

Peter Jurutka is a tenured Professor in the New College of Interdisciplinary Arts and Sciences at Arizona State University (ASU) and a Professor at the University of Arizona College of Medicine-Phoenix. He is a founding faculty member of the latter and has held roles at both institutions since joining ASU in 2004. His research focuses on molecular endocrinology, vitamin D signaling, and the interplay between hormones and disease. Jurutka leads the Molecular Endocrinology Laboratory at ASU Health Futures Center, collaborating with institutions like Mayo Clinic and Phoenix Children’s Hospital. Education: Ph.D. in Biochemistry (University of Arizona), B.S. in Chemistry (University of Nevada). Research Interests: Jurutka’s work explores gene-environment interactions, anti-aging mechanisms, and chemoprevention. Key projects include studying vitamin D’s role in serotonin production, IBS/IBD pathophysiology, and rexinoid drug design for cancer and Alzheimer’s. His lab pioneered findings linking vitamin D to serotonin regulation in brain cells, impacting autism and depression research. Collaborations span microbiome analysis, drug development, and biomarker discovery. Articles Trends: Recent work emphasizes microbiome profiling in IBD, synthetic rexinoid development, and vitamin D’s systemic effects. Studies highlight synergistic drug interactions, differential gene expression in brain/glioblastoma cells, and the role of cytochrome P450 enzymes in vitamin D metabolism. Awards: Norwich-Eaton Young Investigator Award, John Haddad Young Investigator Award, ASU Faculty Achievement Award (Mentoring). Grants & Advising: Jurutka has secured grants for Alzheimer’s therapies, IBS biomarker research, and RXR agonist development. He mentors students, many of whom co-author papers on topics like IBS genetics and chemoprevention. His lab also explores vaccine adjuvants and mucosal homing of T-cells. Labs/Teams: Jurutka directs the Molecular Endocrinology Lab and collaborates with interdisciplinary teams at ASU’s Biodesign Institute, Mayo Clinic, and Phoenix Children’s Hospital. Research outcomes are published in high-impact journals like Journal of Bone and Mineral Research and Scientific Reports .

Steve Presseمشاهده پروفایل

استاد

• Biophysics
• Statistical Physics
• Machine Learning
• +۵ مورد دیگر

Steve Presse is a Professor at Arizona State University (ASU), affiliated with the School of Molecular Sciences and the Department of Physics. He holds roles in the Biodesign Center for Mechanisms of Evolution, Mechanisms of Evolution Researchers, and the Center for Biological Physics. His research focuses on integrating Bayesian inference, machine learning, and statistical physics to study living systems, with experimental work on bacterial hydrodynamics and predation. Education: Ph.D. in Chemical Physics from MIT (2008). Research Interests: Bayesian methods, ML/AI in biophysics, single-molecule analysis, and stochastic processes. Experimental studies include bacterial interactions and predator-prey dynamics. Research Trends: Recent work emphasizes single-molecule reaction-diffusion, Bayesian inference for binding kinetics, and deep learning applications in biophysical data. Themes include superresolved tracking, fluorescence microscopy analysis, and modeling complex biological systems. Lab & Collaborations: The Pressé Lab actively recruits postdocs, graduate, and undergraduate students. Collaborations focus on developing computational tools for data modeling, as seen in his textbook Data Modeling for the Sciences .

• Neurodegenerative Diseases
• Biophysics
• Molecular Biology
• +۵ مورد دیگر

Carol Huseby is a Research Professor at Arizona State University (ASU), affiliated with the School of Life Sciences and the ASU-Banner Neurodegenerative Disease Research Center. She holds appointments in the Neuroscience (PhD) program and conducts research on neurodegenerative diseases. Education: B.Sc. Physics and Biology, University of Washington, Seattle M.Sc. Applied Mathematics (neuronal firing models) Ph.D. Biophysics, The Ohio State University (focus: Alzheimer’s disease and tau protein aggregation) Research: Her work investigates molecular mechanisms underlying neurodegenerative diseases like Alzheimer’s, Parkinson’s, ALS, and frontotemporal dementia. Key areas include structural biology of protein aggregates, transcriptional changes in disease progression, and cryo-electron microscopy applications. She explores how protein structure-function relationships drive disease-specific pathologies. Awards: NRSA NIH Postdoctoral Fellowship Teaching/Advising: She oversees undergraduate research and honors thesis programs (BIO 492/493/495). No specific grants mentioned, but her postdoctoral work was supported by the Arizona Alzheimer’s Consortium. Labs/Teams: Active in the NDRC Biodesign Center, focusing on neurodegenerative disease comparisons and early molecular mechanisms.

• Biochemistry
• Biophysics
• Photosynthesis
• +۵ مورد دیگر

Neal Woodbury is Vice President & Chief Science & Technology Officer at Arizona State University's Knowledge Enterprise, concurrently serving as a Professor in the School of Molecular Sciences and the Biodesign Center for Innovations in Medicine. He holds affiliations with the Julie Ann Wrigley Global Futures Laboratory and the Global Security Initiative. With a PhD from the University of Washington (1986) and a BS from UC Davis (1979), Woodbury specializes in electron transfer dynamics, photosynthesis, and synthetic biology. His research spans chemical diversity generation, synthetic antibodies (Synbodies), and energy conversion catalysts. He has published >165 works and holds seven patents, including foundational contributions to immunosignaturing technology. Notable awards include National Academy of Inventors Fellowship. Research Interests: Chemical diversity platforms (mRNA display, light-directed synthesis), synthetic antibody development, bio-inspired energy systems, optically directed cellular evolution, ultrafast laser spectroscopy, and chromatin dynamics. Recent work focuses on DNA-based excitonic circuits, nanocaged enzymes, and biomimetic solar energy systems. Scientific Contributions: Over 165 peer-reviewed publications and patents in biophysics, nanotechnology, and energy science. Key projects include HealthTell's immunosignaturing platform and development of DNA-templated energy transfer systems. Active in translational research, including collaborations with Science Foundation Arizona and the Biodesign Institute. Grants & Leadership: Directed >40 grants including NSF-MURI on enzyme systems, DOE projects on water-splitting catalysts, and NIH initiatives in biomolecular nanotechnology. Served as Deputy Director of the Biodesign Institute and co-Director of the Center for Innovations in Medicine. Education & Mentorship: Advised numerous graduate students and postdocs, taught advanced courses in research techniques and biotechnology. Involved in training programs such as the IGERT in Biomolecular Nanotechnology.

• Neurodegenerative Diseases
• Epigenetics
• Alzheimer's Disease
• +۵ مورد دیگر

Diego Mastroeni is a Research Associate Professor at Arizona State University (ASU), affiliated with the ASU-Banner Neurodegenerative Disease Research Center and the Biodesign Institute. His work focuses on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s, with a strong emphasis on epigenetics, mitochondrial dysfunction, and microglial biology. He holds a PhD in Neuroscience from Maastricht University and conducted postdoctoral training at the Banner Sun Health Research Institute. Research Interests: Epigenetic mechanisms in neurodegeneration Microglial and neuronal heterogeneity Single-cell transcriptomics Alzheimer’s disease biomarkers Age-related neurodegeneration Key Projects: Ongoing Alzheimer’s Association grant (2018–2021): Investigating gender effects in Alzheimer’s cell populations NOMIS Foundation-funded project (2018–2023): Creating a public resource of brain cell RNA sequencing data EU JPND Research initiative (2017–2021): Targeting epigenetic dysregulation in Alzheimer’s Publications: Over 40 peer-reviewed articles, including seminal work on DNA methylation in Alzheimer’s and laser capture microdissection techniques. Recent focus on microglial transcriptomics and novel therapeutic targets. Teaching: Involvement in undergraduate research courses (e.g., BCH 392, BIO 495) emphasizing research techniques and honors thesis supervision.

• Immunology
• Cell Biology
• Microbiology
• +۵ مورد دیگر

Michele Di Palma is an Instructor in the School of Life Sciences at Arizona State University (ASU), affiliated with the Biodesign Center for Fundamental & Applied Microbiomics. Her research focuses on leveraging microbiome science to enhance cancer therapies, particularly in immunocompromised patients and tumor microenvironment contexts. She holds a PhD (2023) and MS (2018) in Molecular and Cellular Biology from ASU, alongside a BS in Molecular Biosciences and Biotechnology (2017). Her research interests span immunology, cell biology, and microbiology with emphasis on T cell function modulation, microbiome-tumor interactions, and vaccine development. Recent work explores microbiome modulations' impact on immunotherapy efficacy for metastatic osteosarcoma and herpes simplex virus neutralization strategies. Publications highlight innovations in plant-based protein production and T-cell epitope prediction algorithms. Teaching responsibilities include courses in immunology, cell biology, and general biology, with emphasis on molecular & cellular foundations. Her instructional portfolio spans undergraduate and graduate levels, including specialized topics in microbiology and molecular biosciences. Active research collaborations involve ASU's Biodesign Center and international journals in immunology and bioengineering.

• Biomedical Engineering
• Clinical Sciences
• Sports Science and Exercise
• +۶ مورد دیگر

Associate Professor Devakar Epari is a biomedical engineer specializing in orthopaedic trauma and the Subject Area Coordinator for Medical Engineering at QUT's Faculty of Engineering. He holds a PhD from Technische Universität Berlin and dual undergraduate degrees in biomedical and mechanical engineering from the University of New South Wales. His research focuses on fracture fixation mechanics, bone healing mechanisms, and medical device innovation, including co-developing the CE-marked Biphasic Plating concept. Epari teaches courses in biomechanical engineering design, modeling, and medical legislation, and actively supervises PhD students exploring fracture healing dynamics and implant design. Education: PhD in Biomedical Engineering, Technische Universität Berlin Master of Biomedical Engineering, UNSW Sydney Bachelor of Engineering (Mechanical), UNSW Sydney Key Research Contributions: Biphasic Plating technology for distal femur fractures Investigations into mechanical stimulation timing and fixation stiffness modulation Development of active fixator systems and scaffold-based bone regeneration strategies His work bridges biomechanics, mechanobiology, and clinical practice, with over 20 peer-reviewed publications and involvement in major initiatives like Biodesign Australia. Awards include editorial roles at BMJ Innovations. Ongoing projects focus on joint biomechanics and regenerative medicine, supported by ARC grants totaling AUD millions. Epari collaborates globally, maintaining ties to institutions in Germany, Switzerland, and India.

• Bioengineering
• Immunomodulatory Biomaterials
• Cardiovascular Research
• +۳ مورد دیگر

Dr. Richard Tan is a Senior Lecturer in the School of Medical Sciences at the University of Sydney, where he leads the Bio-Informed Engineering group. He holds dual fellowships: Heart Foundation Postdoctoral Fellow and ARC Early Career Industry Fellow. His research bridges biomedical engineering and immunobiology to develop novel vascular therapies. Education: BSc, Georgia Institute of Technology (2008) MEng, Georgia Institute of Technology PhD in Immunomodulatory Biomaterials (2019), Heart Research Institute His multidisciplinary work focuses on: Immunomodulatory biomaterials for vascular disease Bioengineering of artificial blood vessels Plasma-polymerized nanoparticle drug delivery Diabetes-impacted vascular function Alzheimer’s disease neuroinflammation Orthopedic implant durability Recent publications emphasize biomaterial immunocompatibility, with 12/26 articles in 2023-2024 focusing on vascular grafts, inflammation, and regenerative therapies. His research is supported by grants from: National Health and Medical Research Council NSW Health Cardiovascular Initiative Juvenile Diabetes Research Foundation ARC Early Career Fellowship Current advisees include: Angus – Developing immunomodulatory solutions for cardiovascular devices Shereen – Biodesign of cardiovascular materials

Matthew Tarnowskiمشاهده پروفایل

پژوهشگر

• Microbiology
• Bioinformatics
• Environmental Science
• +۴ مورد دیگر

Dr. Matthew Tarnowski is a Researcher at Swansea University's School of Biosciences, Geography and Physics, specializing in microbiology and bioinformatics. He leads the search for plastic-degrading enzymes through DNA/RNA sequencing as part of the EU-funded BMRex project. His work emphasizes responsible research and innovation , public engagement , and transdisciplinary collaboration . Education: PhD from the University of Bristol (2011–2018). Prior roles include Graduate Researcher at AstraZeneca (2014–2016). Current projects include agroecology initiatives and microbial research at the National Botanic Gardens of Wales. Research Interests: Microbial ecology, biodegradation pathways, and ethical frameworks for biotechnology. He bridges environmental science and societal engagement through projects like the Farming with Fungi initiative. Grants/Projects: Principal Investigator on the BMRex project (2023–2025), focusing on biocatalytic membranes for plastic degradation. Collaborates with Associate Prof. Eva Sonnenschein. Engagement: Public microplastic collection campaign via Swansea University's Greatest Need Fund. Presented at workshops like 'Environmental Microbiology: Microbes as Safeguards of the Environment' (Spain, 2024).